• Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye

  • Nov 2 2022
  • Duración: 9 m
  • Podcast
Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye  Por  arte de portada

Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye

  • Resumen

  • Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Sumitovant + Myovant
    Thermo Fisher + Binding Site Group
    Astellas & Taysha
    Agios
    Vaxctye

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    Más Menos

Lo que los oyentes dicen sobre Sumitovant + Myovant, Thermo Fisher + Binding Site Group, Astellas & Taysha, Agios, Vaxctye

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.